{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,11]],"date-time":"2024-06-11T09:02:16Z","timestamp":1718096536635},"reference-count":34,"publisher":"Akademiai Kiado Zrt.","issue":"13","license":[{"start":{"date-parts":[[2021,3,28]],"date-time":"2021-03-28T00:00:00Z","timestamp":1616889600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["akjournals.com"],"crossmark-restriction":true},"short-container-title":["OH"],"published-print":{"date-parts":[[2021,3,28]]},"abstract":"<jats:p><jats:bold>\u00d6sszefoglal\u00f3.<\/jats:bold>\n                    <jats:italic>Bevezet\u00e9s:<\/jats:italic> Heveny myocardialis infarctusban a sz\u00edvizomment\u00e9s\n                    sikere, a beteg \u00e9letkil\u00e1t\u00e1sa nagym\u00e9rt\u00e9kben f\u00fcgg a panasz kezdete \u00e9s az\n                    elz\u00e1r\u00f3dott koszor\u00fa\u00e9r rekanaliz\u00e1l\u00e1sa k\u00f6z\u00f6tt eltelt ischaemi\u00e1s id\u0151t\u0151l. Jelenleg az\n                    \u00e9r nyit\u00e1sa optim\u00e1lis esetben minden betegn\u00e9l koszor\u00fa\u00e9r-intervenci\u00f3val t\u00f6rt\u00e9nik.\n                        <jats:italic>C\u00e9lkit\u0171z\u00e9s:<\/jats:italic> Annak vizsg\u00e1lata, hogy \u00f6t \u00e9v alatt mennyit\n                    v\u00e1ltoztak az ischaemi\u00e1s id\u0151 \u00f6sszetev\u0151i, \u00e9s miben v\u00e1ltozott az elz\u00e1r\u00f3dott \u00e9r\n                    nyit\u00e1s\u00e1nak m\u00f3dszere ST-elev\u00e1ci\u00f3s myocardialis infarctus (STEMI) miatt v\u00e9gzett\n                    primer coronariaintervenci\u00f3ban. <jats:italic>M\u00f3dszer:<\/jats:italic> 2014. 01. 01. \u00e9s 2018.\n                    12. 31. k\u00f6z\u00f6tt 1663, STEMI miatt koszor\u00fa\u00e9r-intervenci\u00f3val kezelt betegn\u00e9l (1173\n                    f\u00e9rfi \u00e9s 490 n\u0151) vizsg\u00e1ltuk \u00e9venk\u00e9nti bont\u00e1sban a panaszt\u00f3l a koszor\u00fa\u00e9r\n                    nyit\u00e1s\u00e1ig eltelt id\u0151 \u00f6sszetev\u0151it \u00e9s a 30 napos hal\u00e1loz\u00e1st.\n                        <jats:italic>Eredm\u00e9nyek:<\/jats:italic> \u00d6t \u00e9v alatt a panaszt\u00f3l az els\u0151 eg\u00e9szs\u00e9g\u00fcgyi\n                    kontaktusig medi\u00e1n 2:53 vs. 2:10 \u00f3ra (p = 0,0132), ett\u0151l az intervenci\u00f3s\n                    centrumba t\u00f6rt\u00e9nt felv\u00e9telig medi\u00e1n 1:17 vs. 1:03 \u00f3ra (p = 0,009), a felv\u00e9telt\u0151l\n                    a ballon nyit\u00e1s\u00e1ig medi\u00e1n 0:31 vs. 0:29 \u00f3ra (p = ns) telt el. A panaszt\u00f3l a\n                    ballon nyit\u00e1s\u00e1ig eltelt id\u0151 (medi\u00e1n 5:29 vs. 4:07 \u00f3ra, p = 0,0001) r\u00f6vid\u00fclt,\n                    d\u00f6nt\u0151en 2014 \u00e9s 2015 k\u00f6z\u00f6tt. A gy\u00f3gyszerkibocs\u00e1t\u00f3 stent be\u00fcltet\u00e9se 15%-r\u00f3l\n                    96%-ra n\u0151tt. A vizsg\u00e1lt \u00e9vekben a l\u00e9gz\u00e9s\/kering\u00e9s t\u00e1mogat\u00e1s ar\u00e1nya\n                    8,2\u201310,6\u201313,9\u20137,6\u20138,4, a 30 napos hal\u00e1loz\u00e1s\u00e9 4,1\u20136,8\u201311,1\u20137,4\u20135,7% volt; a k\u00e9t\n                    \u00e9rt\u00e9k korrel\u00e1ci\u00f3t mutat (p = 0,827). <jats:italic>K\u00f6vetkeztet\u00e9s:<\/jats:italic> \u00d6t \u00e9v alatt\n                    a panaszt\u00f3l az els\u0151 eg\u00e9szs\u00e9g\u00fcgyi kontaktusig \u00e9s a k\u00f3rh\u00e1zi besz\u00e1ll\u00edt\u00e1sig eltelt\n                    id\u0151 r\u00f6vid\u00fclt, de az Eur\u00f3pai Kardiol\u00f3giai T\u00e1rsas\u00e1g aj\u00e1nl\u00e1s\u00e1hoz k\u00e9pest hossz\u00fa; a\n                    k\u00f3rh\u00e1zi felv\u00e9telt\u0151l a ballon nyit\u00e1s\u00e1ig eltelt id\u0151 megfelel\u0151. A n\u00e9gy \u00f3r\u00e1n bel\u00fcli\n                    reperf\u00fazi\u00f3 a betegek k\u00f6zel fel\u00e9ben val\u00f3sult meg. Az intervenci\u00f3s centrumba val\u00f3\n                    gyorsabb beker\u00fcl\u00e9s jav\u00edthatna az eredm\u00e9nyen. Orv Hetil. 2021; 162(13):\n                    497\u2013503.<\/jats:p>\n                <jats:p><jats:bold>Summary.<\/jats:bold>\n                    <jats:italic>Introduction:<\/jats:italic> In acute myocardial infarction, the heart muscle\n                    salvage, the patient\u2019s life expectancy is highly dependent on the elapsed\n                    ischaemic time from the onset of complaint to target vessel recanalisation.\n                    Nowadays, target vessel recanalisation is performed with coronary intervention\n                    in all patients in optimal case. <jats:italic>Objective:<\/jats:italic> To examine how the\n                    components of ischemic time and the opening procedure of the occluded coronary\n                    have changed over five years in primary intervention done in acute ST-elevation\n                    myocardial infarction (STEMI). <jats:italic>Method:<\/jats:italic> Authors studied data of\n                    1663 (1173 male and 480 female) STEMI patients in annual breakdowns treated with\n                    coronary intervention between 01. 01. 2014 and 31. 12. 2018, time from complaint\n                    to coronary artery opening, details of intervention and 30 days mortality rate.\n                        <jats:italic>Results:<\/jats:italic> During the five years, time intervals were as\n                    follows: from onset of complaint to first medical contact: median 2:53 vs. 2:10\n                    hours (p = 0.0132), from this to admission in the interventional centre: median\n                    1:17 vs. 1:03 hours (p = 0.009), from hospital admission to balloon opening:\n                    median 0:31 vs. 0:29 hours (p = ns). In total, the complaint to balloon opening\n                    time (median 5:29 vs. 4:07 hours, p = 0.0001) diminished, decisively from 2014\n                    to 2015. Ratio of drug-eluting stent implantation increased from 15% to 96%. In\n                    the investigated years, the need of respiratory and\/or circulatory device\n                    support ratio was 8.2\u201310.6\u201313.9\u20137.6\u20138.4, 30-day mortality rate between\n                    4.1\u20136.8\u201311.1\u20137.4\u20135.7%; these two values showed a correlation (p = 0.827).\n                        <jats:italic>Conclusion:<\/jats:italic> The time from complaint to first medical\n                    contact and transfer to hospital against the significant decrease is still\n                    longer than the recommendation of the European Society of Cardiology. The time\n                    from hospital admission to balloon opening is adequate. Reperfusion within four\n                    hours was achieved in half of the patients in total. Faster hospitalization may\n                    improve results. Orv Hetil. 2021; 162(13): 497\u2013503.<\/jats:p>","DOI":"10.1556\/650.2021.31907","type":"journal-article","created":{"date-parts":[[2021,3,29]],"date-time":"2021-03-29T13:37:26Z","timestamp":1617025046000},"page":"497-503","update-policy":"http:\/\/dx.doi.org\/10.1556\/policypage.crossmark.crossref.1","source":"Crossref","is-referenced-by-count":2,"title":["Primer coronariaintervenci\u00f3 ST-elev\u00e1ci\u00f3s infarktusban"],"prefix":"10.1556","volume":"162","author":[{"given":"L\u00e1szl\u00f3","family":"Voith","sequence":"first","affiliation":[{"name":"1 Semmelweis Egyetem, V\u00e1rosmajori Sz\u00edv- \u00e9s \u00c9rgy\u00f3gy\u00e1szati Klinika, Budapest, V\u00e1rosmajor u. 68., 1122"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Istv\u00e1n Ferenc","family":"\u00c9des","sequence":"additional","affiliation":[{"name":"1 Semmelweis Egyetem, V\u00e1rosmajori Sz\u00edv- \u00e9s \u00c9rgy\u00f3gy\u00e1szati Klinika, Budapest, V\u00e1rosmajor u. 68., 1122"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fanni","family":"Nowotta","sequence":"additional","affiliation":[{"name":"1 Semmelweis Egyetem, V\u00e1rosmajori Sz\u00edv- \u00e9s \u00c9rgy\u00f3gy\u00e1szati Klinika, Budapest, V\u00e1rosmajor u. 68., 1122"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R\u00e9ka","family":"Skoda","sequence":"additional","affiliation":[{"name":"1 Semmelweis Egyetem, V\u00e1rosmajori Sz\u00edv- \u00e9s \u00c9rgy\u00f3gy\u00e1szati Klinika, Budapest, V\u00e1rosmajor u. 68., 1122"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gy\u00f6rgy","family":"B\u00e1rczi","sequence":"additional","affiliation":[{"name":"1 Semmelweis Egyetem, V\u00e1rosmajori Sz\u00edv- \u00e9s \u00c9rgy\u00f3gy\u00e1szati Klinika, Budapest, V\u00e1rosmajor u. 68., 1122"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B\u00e9la","family":"Merkely","sequence":"additional","affiliation":[{"name":"1 Semmelweis Egyetem, V\u00e1rosmajori Sz\u00edv- \u00e9s \u00c9rgy\u00f3gy\u00e1szati Klinika, Budapest, V\u00e1rosmajor u. 68., 1122"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D\u00e1vid","family":"Becker","sequence":"additional","affiliation":[{"name":"1 Semmelweis Egyetem, V\u00e1rosmajori Sz\u00edv- \u00e9s \u00c9rgy\u00f3gy\u00e1szati Klinika, Budapest, V\u00e1rosmajor u. 68., 1122"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"425","reference":[{"key":"ref0","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1161\/01.CIR.74.3.469","article-title":"Limitation of myocardial ischemia by collateral circulation during sudden controlled coronary artery occlusion in human subjects: a prospective study","volume":"74","author":"Cohen M","year":"1986","unstructured":"1 Cohen M, Rentrop P. Limitation of myocardial ischemia by collateral circulation during sudden controlled coronary artery occlusion in human subjects: a prospective study. Circulation 1986; 74: 469-476.","journal-title":"Circulation"},{"key":"ref1","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1161\/01.CIR.74.5.1124","article-title":"Preconditioning with ischaemia: a delay of lethal cell injury in ischaemic myocardium","volume":"74","author":"2 Murry","year":"1986","unstructured":"2 Murry CE, Jennings RB, Reimer KA. Preconditioning with ischaemia: a delay of lethal cell injury in ischaemic myocardium. Circulation 1986; 74: 1124-1136.","journal-title":"Circulation"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1161\/01.RES.72.6.1293","article-title":"Delayed effects of sublethal ischaemia on the acquisition of tolerance to ischaemia","volume":"72","author":"3 Kuzuyama","year":"1993","unstructured":"3 Kuzuyama T, Hoshida S, Yamashita N, et al. Delayed effects of sublethal ischaemia on the acquisition of tolerance to ischaemia. Circ Res. 1993; 72: 1293-2009.","journal-title":"Circ Res"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"4 Figueras J, Otaeugui I, Marti G, et al. Area at risk and collateral circulation in a first acute myocardial infarction with occluded culprit artery. STEMI vs. non-STEMI patients. Int J Cardiol. 2018; 259: 14-19.","DOI":"10.1016\/j.ijcard.2018.01.047"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1056\/NEJM198703193161201","article-title":"Intravascular stents to prevent occlusion and restenosis after transluminal angioplasty","volume":"316","author":"5 Sigwart","year":"1987","unstructured":"5 Sigwart U, Puel J, Mirkovitch J, et al. Intravascular stents to prevent occlusion and restenosis after transluminal angioplasty. N Engl J Med. 1987; 316: 701-706.","journal-title":"N Engl J Med"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1016\/S0140-6736(07)61444-5","article-title":"Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis","volume":"370","author":"6 Stettler","year":"2007","unstructured":"6 Stettler C, Wandel S, Allemann S, et al. Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis. Lancet 2007; 370: 937-948.","journal-title":"Lancet"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"1933","DOI":"10.1056\/NEJMoa0809902","article-title":"Long-term safety and efficacy of drug-eluting versus bare-metal stents in Sweden","volume":"360","author":"7 James","year":"2009","unstructured":"7 James SK, Stenestrand U, Lindb\u00e4ck J, et al., for the SCAAR Study Group. Long-term safety and efficacy of drug-eluting versus bare-metal stents in Sweden. N Engl J Med. 2009; 360: 1933-1945.","journal-title":"N Engl J Med"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/S0140-6736(15)00548-6","article-title":"Clinical outcomes in patients with ST-segment elevation myocardial infarction treated with everolimus-eluting stents versus bare-metal stents (EXAMINATION): 5-year results of a randomised trial","volume":"387","author":"8 Sabat\u00e9","year":"2016","unstructured":"8 Sabat\u00e9 M, Brugaletta S, Cequier A, et al. Clinical outcomes in patients with ST-segment elevation myocardial infarction treated with everolimus-eluting stents versus bare-metal stents (EXAMINATION): 5-year results of a randomised trial. Lancet 2016; 387: 357-366.","journal-title":"Lancet"},{"key":"ref8","unstructured":"9 Voith L. Is it necessary to implant drug eluting stent in every dilated coronary artery stenosis? [Kell-e minden t\u00e1g\u00edtott koszor\u00fa\u00e9r-sz\u0171k\u00fcletbe gy\u00f3gyszerkibocs\u00e1t\u00f3 stentet \u00fcltetni?] Cardiol Hung. 2010; 40: 294-299. [Hungarian]"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1016\/j.jacc.2013.05.022","article-title":"Clinical outcomes with drug-eluting and bare-metal stents in patients with ST-segment elevation myocardial infarction: evidence from a comprehensive network meta-analysis","volume":"62","author":"10 Palmerini","year":"2013","unstructured":"10 Palmerini T, Biondi-Zoccai G, Della Riva D, et al. Clinical outcomes with drug-eluting and bare-metal stents in patients with ST-segment elevation myocardial infarction: evidence from a comprehensive network meta-analysis. J Am Coll Cardiol. 2013; 62: 496-504.","journal-title":"J Am Coll Cardiol"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/S0140-6736(03)12113-7","article-title":"Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials","volume":"361","author":"11 Keeley","year":"2003","unstructured":"11 Keeley EC, Boura JA, Grines CL. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. Lancet 2003; 361: 13-20.","journal-title":"Lancet"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"1891","DOI":"10.1001\/jama.290.14.1891","article-title":"Mortality benefit of immediate revascularization of acute ST-segment elevation myocardial infarction in patients with contraindications to thrombolytic therapy: a propensity analysis","volume":"290","author":"12 Grzybowski","year":"2003","unstructured":"12 Grzybowski M, Clements EA, Parsons L, et al. Mortality benefit of immediate revascularization of acute ST-segment elevation myocardial infarction in patients with contraindications to thrombolytic therapy: a propensity analysis. JAMA 2003; 290: 1891-1898.","journal-title":"JAMA"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1093\/eurheartj\/ehi810","article-title":"Does time matter? A pooled analysis of randomized clinical trials comparing primary percutaneous coronary intervention and in-hospital fibrinolysis in acute myocardial infarction patients","volume":"27","author":"Boersma E","year":"2006","unstructured":"13 Boersma E, Primary Coronary Angioplasty vs. Thrombolysis Group. Does time matter? A pooled analysis of randomized clinical trials comparing primary percutaneous coronary intervention and in-hospital fibrinolysis in acute myocardial infarction patients. Eur Heart J. 2006; 27: 779-788.","journal-title":"Eur Heart J"},{"key":"ref13","unstructured":"14 Kom\u00f3csi A, Ungi I, K\u00f3nyi A. Heart catheterisation from radial artery approach. [Sz\u00edvkat\u00e9terez\u00e9s arteria radialis behatol\u00e1sb\u00f3l.] Akad\u00e9miai Kiad\u00f3, Budapest, 2009. [Hungarian]"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"2465","DOI":"10.1016\/S0140-6736(15)60292-6","article-title":"Radial versus femoral access in patients with acute coronary syndromes undergoing invasive management: a randomised multicentre trial","volume":"385","author":"15 Valgimigli","year":"2015","unstructured":"15 Valgimigli M, Gagnor A, Calabr\u00f3 P, et al., MATRIX Investigators. Radial versus femoral access in patients with acute coronary syndromes undergoing invasive management: a randomised multicentre trial. Lancet 2015; 385: 2465-2476.","journal-title":"Lancet"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1093\/eurheartj\/ehx393","article-title":"2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC)","volume":"39","author":"16 Ibanez","year":"2018","unstructured":"16 Ibanez B, James S, Agewall S, et al. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J. 2018; 39: 119-177.","journal-title":"Eur Heart J"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1016\/S0140-6736(96)02514-7","article-title":"Early thrombolytic treatment in acute myocardial infarction: reappraisal of the golden hour","volume":"348","author":"17 Boersma","year":"1996","unstructured":"17 Boersma E, Maas AC, Deckers JW, et al. Early thrombolytic treatment in acute myocardial infarction: reappraisal of the golden hour. Lancet 1996; 348: 771-775.","journal-title":"Lancet"},{"key":"ref17","doi-asserted-by":"publisher","unstructured":"18 Gersh BJ, Antman EM. Selection of the optimal reperfusion strategy for STEMI: does time matter? Eur Heart J. 2006; 27: 761-763.","DOI":"10.1093\/eurheartj\/ehi775"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1001\/jama.2010.1139","article-title":"System delay and mortality among patients with STEMI treated with primary percutaneous coronary intervention","volume":"304","author":"19 Terkelsen","year":"2010","unstructured":"19 Terkelsen CJ, S\u00f8rensen JT, Maeng M, et al. System delay and mortality among patients with STEMI treated with primary percutaneous coronary intervention. JAMA 2010; 304: 763-771.","journal-title":"JAMA"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3109\/10903127.2013.836263","article-title":"Effect of prehospital cardiac catheterization lab activation on door-to-balloon time, mortality, and false-positive activation","volume":"18","author":"20 Squire","year":"2014","unstructured":"20 Squire BT, Tamayo-Sarver JH, Rashi P, et al. Effect of prehospital cardiac catheterization lab activation on door-to-balloon time, mortality, and false-positive activation. Prehosp Emerg Care 2014; 18: 1-8.","journal-title":"Prehosp Emerg Care"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1016\/S0140-6736(14)61932-2","article-title":"Relation between door-to-balloon times and mortality after primary percutaneous coronary intervention over time: a retrospective study","volume":"385","author":"21 Nallamothu","year":"2015","unstructured":"21 Nallamothu BK, Normand SL, Wang Y, et al. Relation between door-to-balloon times and mortality after primary percutaneous coronary intervention over time: a retrospective study. Lancet 2015; 385: 1114-1122.","journal-title":"Lancet"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/j.amjcard.2009.04.016","article-title":"Prevalence, predictors, and in-hospital outcomes of non-infarct artery intervention during primary percutaneous coronary intervention for ST-segment elevation myocardial infarction (from the National Cardiovascular Data Registry)","volume":"104","author":"22 Cavender","year":"2009","unstructured":"22 Cavender MA, Milford-Beland S, Roe MT, et al. Prevalence, predictors, and in-hospital outcomes of non-infarct artery intervention during primary percutaneous coronary intervention for ST-segment elevation myocardial infarction (from the National Cardiovascular Data Registry). Am J Cardiol. 2009; 104: 507-513.","journal-title":"Am J Cardiol"},{"key":"ref22","doi-asserted-by":"publisher","unstructured":"23 Bangalore S, Toklu B, Wetterslev J. Complete versus culprit-only revascularization for ST-segment-elevation myocardial infarction and multivessel disease: a meta-analysis and trial sequential analysis of randomized trials. Circ Cardiovasc Interv. 2015; 8: e002142.","DOI":"10.1161\/CIRCINTERVENTIONS.114.002142"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.jcin.2016.11.047","article-title":"Complete or culprit-only revascularization for patients with multivessel coronary artery disease undergoing percutaneous coronary intervention: a pairwise and network meta-analysis of randomized trials","volume":"10","author":"24 Elgendy","year":"2017","unstructured":"24 Elgendy IY, Mahmoud AN, Kumbhani DJ, et al. Complete or culprit-only revascularization for patients with multivessel coronary artery disease undergoing percutaneous coronary intervention: a pairwise and network meta-analysis of randomized trials. JACC Cardiovasc Interv. 2017; 10: 315-324.","journal-title":"JACC Cardiovasc Interv"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"4103","DOI":"10.1093\/eurheartj\/ehz896","article-title":"Complete revascularization reduces cardiovascular death in patients with ST-segment elevation myocardial infarction and multivessel disease: systematic review and meta-analysis of randomized clinical trials","volume":"41","author":"25 Pavasini","year":"2020","unstructured":"25 Pavasini R, Biscaglia S, Barbato E, et al. Complete revascularization reduces cardiovascular death in patients with ST-segment elevation myocardial infarction and multivessel disease: systematic review and meta-analysis of randomized clinical trials. Eur Heart J. 2020; 41: 4103-4110.","journal-title":"Eur Heart J"},{"key":"ref25","doi-asserted-by":"publisher","unstructured":"26 J\u00e1nosi A, Csat\u00f3 G, Pach FP, et al. Analysis of pre-hospital delay time of patients with myocardial infarction. [Sz\u00edvinfarktus miatt kezelt betegek prehospit\u00e1lis k\u00e9s\u00e9si idej\u00e9nek elemz\u00e9se.] Orv Hetil. 2019; 160: 20-25. [Hungarian]","DOI":"10.1556\/650.2019.31253"},{"key":"ref26","doi-asserted-by":"publisher","unstructured":"27 Becker D, Merkely B. Current therapy of the acute coronary syndrome - 2016. [Akut coronaria szindr\u00f3ma ell\u00e1t\u00e1sa - 2016.] Orv Hetil. 2016; 157: 1500-1506. [Hungarian]","DOI":"10.1556\/650.2016.30574"},{"key":"ref27","doi-asserted-by":"publisher","unstructured":"28 J\u00e1nosi A. Data on the state of care of the patients treated for myocardial infartion. Hungarian Myocardial Infarction Registry 2014-2018. [Adatok a sz\u00edvinfarktus miatt kezelt betegek ell\u00e1t\u00e1s\u00e1nak helyzet\u00e9ro\u030bl. Nemzeti Sz\u00edvinfarktus Regiszter 2014-2018.] Cardiol Hung. 2019; 49: 249-254. [Hungarian]","DOI":"10.26430\/CHUNGARICA.2019.49.4.249"},{"key":"ref28","doi-asserted-by":"publisher","unstructured":"29 J\u00e1nosi A, Erdo\u030bs G, Pach FP, et al. Prognostic significance of the total ischemic time in patients with ST-elevation myocardial infarction. [A teljes ischaemi\u00e1s ido\u030b prognosztikus jelento\u030bs\u00e9ge az ST-elev\u00e1ci\u00f3val j\u00e1r\u00f3 sz\u00edvinfarktus miatt kezelt betegekben.] Orv Hetil. 2018; 159: 1113-1120. [Hungarian]","DOI":"10.1556\/650.2018.31108"},{"key":"ref29","doi-asserted-by":"publisher","unstructured":"30 Sjauw KD, Engstr\u00f6m AE, Vis MM, et al. A systematic review and meta-analysis of intra-aortic balloon pump therapy in ST-elevation myocardial infarction: should we change the guidelines? Eur Heart J. 2009; 30: 459-468.","DOI":"10.1093\/eurheartj\/ehn602"},{"key":"ref30","doi-asserted-by":"publisher","unstructured":"31 Esper SA, Bermudez C, Dueweke EJ, et al. Extracorporeal membrane oxygenation support in acute coronary syndromes complicated by cardiogenic shock. Catheter Cardiovasc Interv. 2015: 86(Suppl 1): S45-S50.","DOI":"10.1002\/ccd.25871"},{"key":"ref31","doi-asserted-by":"publisher","unstructured":"32 Voith L, Nowotta F, Skoda R, et al. Coronary angioplasty in serious myocardial infarction with device supported respiration and circulation. [Koszor\u00fa\u00e9r-angioplasztika s\u00falyos miokardi\u00e1lis infarktusban a l\u00e9gz\u00e9s \u00e9s a kering\u00e9s eszk\u00f6z\u00f6s t\u00e1mogat\u00e1s\u00e1val.] Cardiol Hung. 2020; 50: 106-110. [Hungarian]","DOI":"10.26430\/CHUNGARICA.2020.50.2.106"},{"key":"ref32","unstructured":"33 J\u00e1nosi A, Ofner P, Merkely B, et al. Short and long term prognosis of patients with myocardial infarction. Hungarian Myocardial Infarction Registry. [Sz\u00edvinfarktus miatt kezelt betegek korai \u00e9s k\u00e9s\u0151i progn\u00f3zisa. Magyar Infarctus Regiszter Vizsg\u00e1lat.] Orv Hetil. 2013; 154: 1297-1302. [Hungarian]"},{"key":"ref33","unstructured":"34 European Commission - Eurostat Statistic Explained. Standardised death rates - diseases of the circulatory system, residents, 2016 (per 100 000 male female inhabitants). Luxembourg City, 20 November, 2019 (latest revision). Available from: https:\/\/ec.europa.eu\/eurostat\/statistics-explained\/index.php?title=File:Standardised_death_rates_%E2%80%94_diseases_of_the_circulatory_system,_residents,_2016_(per_100_000_male_female_inhabitants)_Health2019.png&oldid=459245 [accessed: Augustus 19, 2020]."}],"container-title":["Orvosi Hetilap"],"original-title":[],"link":[{"URL":"https:\/\/akjournals.com\/view\/journals\/650\/162\/13\/article-p497.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/akjournals.com\/downloadpdf\/journals\/650\/162\/13\/article-p497.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T13:56:12Z","timestamp":1698760572000},"score":1,"resource":{"primary":{"URL":"https:\/\/akjournals.com\/view\/journals\/650\/162\/13\/article-p497.xml"}},"subtitle":["V\u00e1ltoz\u00e1sok \u00f6t \u00e9v alatt"],"short-title":[],"issued":{"date-parts":[[2021,3,28]]},"references-count":34,"journal-issue":{"issue":"13"},"URL":"https:\/\/doi.org\/10.1556\/650.2021.31907","relation":{},"ISSN":["0030-6002","1788-6120"],"issn-type":[{"value":"0030-6002","type":"print"},{"value":"1788-6120","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,28]]}}}